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Abstract
Postprandial lipemia is an independent risk factor for development of cardiovascular disease. Postprandial
inflammation following the prolonged elevation of triglycerides occurring subsequent to ingestion of high-fat
meals, provides a likely explanation for increased disease risk. Substantial evidence has shown that acute exercise is
an effective modality for attenuation of postprandial lipemia following a high-fat meal. However, much of the
evidence pertaining to exercise intensity, duration, and overall energy expenditure for reducing postprandial
lipemia is inconsistent. The effects of these different exercise variables on postprandial inflammation is largely
unknown. Long-term, frequent exercise, however, appears to effectively reduce systemic inflammation, especially in
at-risk or diseased individuals. With regard to an acute postprandial response, without a recent bout of exercise,
high levels of chronic exercise do not appear to reduce postprandial lipemia. This review summarizes the current
literature on postprandial and inflammatory responses to high-fat meals, and the roles that both acute and chronic
exercise play. This review may be valuable for health professionals who wish to provide evidence-based, pragmatic
advice for reducing postprandial lipemia and cardiovascular disease risk for their patients. A brief review of
proposed mechanisms explaining how high-fat meals may result in pro-inflammatory and pro-atherosclerotic
environments is also included.
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Background
The typical Western diet is characterized by sizable por-
tions of highly processed foods, large amounts of added
sugars, and a high total fat content. The average fat con-
tent of a Western meal is between 20 and 40 g, and
three to four meals per day are consumed regularly [1].
Therefore, many individuals spend the majority of their
day in a postprandial state, characterized by elevated
levels of circulating triglycerides (TRG) following a meal.
As Western diet patterns have become commonplace in
developed countries around the world, atherosclerotic
related deaths have also increased [2]. Extensive research
over the last several decades has focused on one of the
main components of the Western diet, the high-fat con-
tent, and its role in the development of atherosclerosis.
Throughout much of the 20th century, atherosclerosis
was thought to be merely a disease of excess lipids in the
bloodstream. However, recent evidence has shown the
progression of the disease to be more related to inflamma-
tion within the blood vessel wall [3]. Accordingly, individ-
uals with elevated levels of systemic inflammation have
been shown to have an increased risk for sudden cardiac
events and mortality [4–6]. Previous research suggests
that even a single high-fat meal (HFM) may induce post-
prandial inflammation [7, 8] and endothelial dysfunction
[9], due to the prolonged elevation of TRG in the blood
stream known as postprandial lipemia (PPL) [10]. Al-
though there is no widely agreed upon definition of PPL,
postprandial lipemia may be defined as the prolonged ele-
vation of TRG and triyglyceride-rich lipoproteins (TRLs)
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in circulation following the consumption of a meal. A pro-
longed elevation of TRG allows for high-density lipopro-
teins (HDL) to be cleared from the blood stream more
easily [11], and for small, atherogenic low-density lipopro-
tein (LDL) particles to form [12].
Evidence suggests that PPL may be attenuated through
acute bouts of exercise as well as chronic aerobic training
[13, 14]. Furthermore, highly active individuals tend to
have lower levels of systemic inflammation as compared
to less active individuals [15]. However, the benefits of
acute exercise for postprandial lipemia appear to be rela-
tively short lived. Only a few days without exercise may
completely negate any attenuation of PPL following the
last bout of exercise [16]. Due to the short-term effects of
acute exercise on PPL, researchers have examined how ex-
ercise timing, type, and intensity, may impact the lipid
lowering effects of exercise [17]. The majority of these
studies have focused on TRG clearance from circulation;
however, how TRG clearance effects the relationship be-
tween acute exercise and postprandial inflammation is not
well understood. Understanding how exercise effects cir-
culating TRG is important due to the pro-inflammatory
and pro-atherosclerotic environment resulting from pro-
longed elevations of TRG. However, postprandial TRG
must be examined along with other physiological pro-
cesses occurring during exercise that may affect the post-
prandial inflammatory environment.
In this review we will discuss the postprandial inflam-
matory response to high-fat, high-calorie, Western style
meals, and the roles of both acute and chronic exercise
as methods of attenuating PPL and inflammation. A
brief review of proposed mechanisms explaining how
high-fat meals may result in pro-inflammatory and pro-
atherosclerotic environments will also be included.
Methods
Data sources
The primary database that was searched was PubMed
with minor contributions from studies found via Google
Scholar.
Key words
All of the following key words were used in different
combinations in an attempt to cover the most thorough
breadth of the research as possible. These terms include
“postprandial” or “post-prandial”, “post-meal”, “lipemia”
or lipaemia”, “triglycerides”, “exercise”, “aerobic”, “resist-
ance”, “high-fat meal”, “inflammation”, “inflammatory”,
“cytokines”, “atherosclerosis”, “heart disease”.
Selection of studies
For studies that discussed postprandial lipemia, the
dependent variable had to be some measure of circulating
triglycerides in the time period following ingestion of a
meal. Unless otherwise noted, studies in which participants
performed exercise were primarily moderate-intensity aer-
obic forms of exercise. Additionally, studies were selected
that focused on healthy, normal lipemic participants except
for when a different population is mentioned within the
context of a referenced study. We had few parameters for
the selection of studies within a given section of the paper.
The authors gave the most weight to the studies that had
been most commonly cited in the literature and were most
up to date. The goal of this review is to provide a narrative
examination of studies that follows the majority of the
weight of evidence for each section. Studies that provide
contrasting evidence are also acknowledged.
Postprandial hyperlipidemia
The magnitude of the postprandial lipid increase is dir-
ectly proportional to the fat content of a meal up to ap-
proximately 80 g [18], and many metabolic processes
determine the overall magnitude and duration of PPL.
Recently digested lipids must be absorbed and secreted
in the form of chylomicrons from the small intestine,
and very low-density lipoproteins (VLDL) are secreted
from the liver. Hereafter, we will refer to chylomicrons
and VLDLs jointly as TRLs in circulation.
Elevated plasma TRLs in the postprandial state are an
independent risk factor for coronary heart disease [19].
The mechanisms through which TRLs cause damage to
the vascular wall are not fully understood; however, the
following proposed mechanisms may help explain the
increased cardiovascular disease risk associated with ele-
vated postprandial TRLs (as illustrated in Fig. 1). In-
creased TRLs in circulation lead to a greater transfer of
triglyceride from TRLs to cholesterol-rich lipoproteins
(mainly HDL) via cholesterol ester transfer protein [12].
This process both depletes HDL [20] and increases con-
centrations of small, dense, LDL and chylomicron (CM)
remnants [21]. These small, dense lipoprotein remnants
appear to have less LDL-receptor binding affinity than
large LDL particles [22], allowing them to stay in circu-
lation longer and become atherogenic through their abil-
ity to penetrate the vascular endothelium [23].
Postprandial inflammatory response
Once the small, dense CM and LDL particles have pene-
trated the vascular endothelium, they are oxidized by re-
active oxygen species (ROS) [24]. Monocytes are recruited
to the endothelial surface by increased expression of vas-
cular cell adhesion molecule-1 (VCAM-1) [25]. VCAM-1
expression may be increased via oxidized LDL particles
that may activate the nuclear factor kappa B (NF-kB)
pathway [26]. Monocytes penetrate the endothelial wall
and become macrophages as they scavenge oxidized lipo-
proteins, as these macrophages accumulate lipid they be-
come foam cells [27]. This buildup of foam cells leads to a
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fatty streak within the blood vessel [28]. This process is
the initiation of an atherosclerotic plaque.
A variety of cytokines are secreted from macrophages
that contribute to the progression of atherosclerosis.
Many of these cytokines, such as interleukin-6 (IL-6)
and tumor necrosis factor- alpha (TNF-α), lead to the
production of downstream cytokines and various other
inflammatory markers that play vital roles in the regula-
tion of atherosclerotic plaques [29]. Although there are
dozens of biomarkers that effect the development of ath-
erosclerosis, we have chosen to focus on a few bio-
markers have been shown to play prominent roles in the
development of atherosclerotic plaques. These markers
include IL-6, TNF-α, interleukin 1β (IL-1β), C-reactive
protein (CRP), and the cellular adhesion molecules
sVCAM-1 and intercellular adhesion molecule-1
(ICAM-1).
A frequently studied biomarker of postprandial inflam-
mation is IL-6. IL-6 is secreted from endothelial cells, T
cells and macrophages within the vascular endothelium,
as well as from adipose tissue [30]. In the context of the
postprandial period, IL-6 is generally considered to be
pro-inflammatory [31]. Evidence has shown that in-
creased levels of IL-6 are correlated with greater occur-
rence of cardiac events [32]. IL-6 also plays an
important role in the synthesis of CRP by the liver [33]
and regulation of TNF-α [34]. Several studies have
shown increases in IL-6 in the postprandial period fol-
lowing high-fat, high-calorie meals [35–37], while others
have not [38, 39]. Studies that have shown increased IL-
6 in the postprandial period, typically have had partici-
pants consume higher total fat and calorie meals than
those that have shown no increase in IL-6. More re-
cently, IL-6 has also been recognized as a myokine, be-
cause of its secretion from skeletal muscle tissue during
exercise [40]. Its role as a myokine is generally consid-
ered to be anti-inflammatory, and will be discussed in
detail later in this review.
Along with IL-6, TNF-α is another commonly mea-
sured pro-inflammatory biomarker. TNF-α is produced
by macrophages, endothelial cells and adipose tissue [41,
42]. TNF-α has been shown to induce the expression of
leukocyte cellular adhesion molecules such as VCAM-1
and ICAM-1 [43]. Additionally, TNF-α may also en-
hance the production of other inflammatory cytokines
[44]. The direction and magnitude of TNF-α responses
in the postprandial period have been mixed. TNF-α may
increase postprandially in overweight participants [37],
and in participants with metabolic syndrome [45]. How-
ever, other studies have reported no change [38, 46] or
even a small decrease [35] in TNF-α postprandially.
These conflicting results are most likely due to differ-
ences in participant characteristics between studies. For
example, TNF-α concentrations may be increased in par-
ticipants with greater abdominal adiposity and/or ad-
vanced age [47, 48].
CRP is one of the classic biomarkers used to assess sys-
temic inflammation. Elevated levels of CRP have been
Fig. 1 The proposed pro-inflammatory pathway following ingestion of a HFM. Triglycerides (TRG), Triglyceride Rich Lipoproteins (TRL), Postprandial
lipemia (PPL), High-density lipoprotein cholesterol (HDL), Low Density Lipoprotein cholesterol (LDL), Nuclear Factor Kappa B (NF-κB), Interleukin 1β (IL-1β),
Interleukin-6 (IL-6), Tumor Necrosis Factor-α (TNF-α). Increased TRG in circulation leads to increase HDL clearance from circulation and an increase in small
dense LDL particles. This process increases subendothelial retention of lipoproteins, leads to oxidized LDL, and activation of the vascular endothelium.
The activated endothelium increases the recruitment of immune cells, mainly monocytes, to the vascular surface to scavenge oxidized LDL molecules.
Accumulation of lipid inside monocytes leads to formation of macrophages and secretion of several pro-inflammatory cytokines. Macrophages
accumulate enough lipid to form foam cells that result in fatty streaks within the vascular endothelium
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shown to be associated with a number of chronic cardio-
vascular diseases including coronary heart disease, hyper-
tension, and stroke [49]. CRP is of particular interest in
the postprandial period because of its downstream re-
sponse to increases in IL-6 [50], its controversial role in
atherosclerotic plaques [51, 52], and specifically in the re-
cruitment of monocytes to the arterial intima [53]. How-
ever, the exact role of CRP in the development of
atherosclerosis is still unclear. It has been well established
that elevated levels of CRP indicate an increased risk for
the development of CVD, but the question of whether or
not CRP has a causal role in the development of CVD still
remains unclear [54]. It is possible that CRP may only be a
marker of inflammation in atherosclerotic plaques result-
ing from acute increases in IL-6 and TNF- α [55]. A re-
view by Herieka and Erridge (2013) indicated only one out
of 30 studies measuring CRP in the postprandial period
found an increase in the acute phase protein in the imme-
diate hours following a HFM [56]. Any significant in-
creases in circulating CRP following a HFM may be found
closer to 24 h after ingestion of the meal after acute in-
creases in IL-6 and TNF- α have already occurred in the
inflammatory cascade.
Interleukin-1β (IL-1β) is a member of the IL-1 family
that has been implicated in nearly all aspects of the ath-
erosclerotic process. IL-1β may be present in monocytes
and macrophages [57], as well as adipose tissue [58].
When secreted, IL-1β may lead to the downstream pro-
duction of other inflammatory markers such as IL-6 and
CRP [59]. IL-1β has been shown to promote a hyper-
triglyceridemic and pro-atherogenic lipid profile through
the increased production and decreased clearance of
VLDLs [60]. Additionally, the pro-inflammatory environ-
ment caused by IL-1β may promote structural changes in
LDL particles that result in the smaller, denser, LDLs that
can more easily penetrate the endothelium and be oxi-
dized [61, 62]. Furthermore, IL-1β may be secreted from
macrophages when they engulf oxidized LDLs, which
would continue stimulation of the inflammatory/pro-
atherogenic environment. IL-1β can directly initiate the
development of atherosclerotic plaques through the re-
cruitment of cellular adhesion molecules, facilitating the
migration of additional inflammatory cells to the vascular
endothelium [63]. IL-1β does not appear to increase after
a high-fat meal in healthy subjects [64, 65], but may in-
crease in individuals with metabolic syndrome [66].
A key aspect of the initial stages of atherosclerosis is
the adhesion of inflammatory cells, mainly leukocytes, to
the vascular endothelium. Two important adhesion mol-
ecules shown to have implications in the development of
atherosclerosis are VCAM-1 [67] and ICAM-1 [68].
These molecules are measured in the blood after they
have been detached from the endothelium and are circu-
lating in their soluble form. VCAM-1 and ICAM-1 are
expressed on the endothelial surface of the blood vessel
wall [69] and upregulated in response to increased con-
centrations of several pro-inflammatory cytokines [70].
These adhesion molecules enable the adhesion and
penetration of leukocytes across the vascular endothe-
lium [69]. Some evidence suggests that increases in sol-
uble adhesion molecules may only occur in an already
pro-atherosclerotic environment [71], such as in diabetic
[72] and hypertriglyceridemic [73] individuals. Addition-
ally, both ICAM-1 and VCAM-1 have been reported to
predict future cardiovascular events in patients with cor-
onary artery disease [5]. Further, postprandial increases
in cellular adhesion molecules in healthy subjects have
been shown to be small [8] or nonexistent [74, 75].
Assessment of PPL and postprandial inflammation
Currently, there is no firmly established protocol for
HFM testing to assess PPL. However, most studies that
have experimentally assessed PPL have used similar pro-
cedures with minor variations. The first consideration
when assessing PPL is the controlling of confounding
lifestyle variables leading up to the testing session. Exer-
cise is well known to decrease the PPL response; it is
usually prohibited for at least 48–60 h prior to the test
meal [13]. Caffeine is also typically excluded for ~24 h
prior to the HFM test. Diet is obviously a very important
factor to control leading up to a PPL session. The extent
to which diet is controlled varies across studies, ranging
from tightly controlled studies that provide meals for
multiple days [76], to studies that only require partici-
pants to log food their food intake and/or keep meals
consistent between trials [46]. However, even more im-
portant than controlling diet is the requirement of en-
suring that individuals fast (for at least 8 h, but typically
10–12 h) prior to their test meal. Metabolic effects of a
single meal can linger for hours, and an individual’s
metabolic state at the onset of a PPL study will affect
their postprandial response. Once in the lab, a baseline
blood draw is performed. In most studies, a cannula is
inserted in a forearm vein to allow for easier repeated
samples [76–78], although some studies do utilize re-
peated venipuncture [8, 79]. Following the baseline/fast-
ing blood draw, the participant will consume the test
meal. Test meals vary greatly between studies – one rea-
son that comparisons across studies can be very difficult.
Meals typically contain >40% fat and >700 kcal, with
some containing more than >60% fat and >1500 kcal
[80]. Most study designs normalize the meal to each par-
ticipant’s body weight, so that the amount of kcals con-
sumed per kilogram of body mass or lean body mass is
the same for each participant [80]. After the meal is con-
sumed, blood draw procedures are repeated for a given
duration at a set frequency. Most studies assess the PPL
response for four [78] to eight hours postprandially [76].
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These blood draws are used to assess several metabolic
markers, with triglycerides as the primary analyte
assessed in most PPL studies. However, there are other
metabolic markers that are occasionally assessed that
can provide additional information regarding the post-
prandial metabolic state. Most of these additional
markers are apolipoproteins or lipoprotein subfractions,
including: total cholesterol, HDL, LDL, apolipoprotein
C3 (ApoC3), which is found on several types of lipopro-
teins of intestinal and hepatic origin; apolipoprotein
B100 (ApoB100), which is found on VLDL, IDL, and
LDL; and remnant cholesterol.
Chronic exercise and PPL
It has been well established that regular exercisers have
a lower postprandial lipemic response compared to non-
exercisers [14, 81]. The triglyceride lowering effects of
frequent exercise are often attributed to increased HDL
concentrations [20], increased post-exercise lipoprotein
lipase (LPL) activity [82], and replenishment of intra-
muscular triglycerides (IMTG) post exercise [83]. In
healthy participants, previous research has indicated that
there is an inverse relationship between HDL-C and PPL
following a HFM [20]. Additionally, participants who
completed a jogging program 3-days/week displayed sig-
nificantly higher plasma LPL concentrations when com-
pared to their own control condition at baseline [84].
The combination of higher HDL-C and LPL concentra-
tions in regularly exercising individuals may allow for
greater replenishment of IMTG and improved clearance
of TRG following exercise. Consistent upregulation of
triglyceride clearing mechanisms may help lower the
mean residence time of LDL in circulation. A shorter
residence time allows less time for more of the small,
dense, LDL particles to form and pose an increased risk
for atherosclerosis [85].
The benefits of exercise training, however; may be
short lived even in the most active individuals [86]. For
example, one study found that after 60 h without exer-
cise, there was no difference in PPL between trained and
untrained subjects. This study compared exercise trained
individuals (half endurance trained, half sprint trained),
to individuals who participated in no more than two, 30-
min exercise sessions per week. Evaluations that oc-
curred at least 60 h following their last bout of exercise
indicated that there were no significant differences in
postprandial triglycerides between endurance-trained,
strength-trained, and untrained participants [86]. Physio-
logical adaptations to detraining, such as reduced aer-
obic capacity, occur over a much longer time period
than 60 h [87]. The effects of exercise on intramuscular
triglyceride replenishment and LPL activity appear to be
absent at 60 h post exercise. Therefore, mechanisms
independent of aerobic capacity are the likely drivers of
exercise attenuated PPL.
Kiens and Richter (1998) investigated the effects of ex-
ercise training on lipid metabolism in endurance-trained
males [83]. Their study focused on IMTG use during
post-exercise recovery and the possible role of LPL in
this process. The authors found that IMTG stores were
diminished post-exercise until 42 h. LPL activity was sig-
nificantly increased the day following exercise, but had
returned to baseline levels at 42 h post-exercise. These
data suggest that circulating TRLs could be broken
down by increased LPL activity, used to replenish IMTG
stores, and provide fuel for post-exercise recovery [83].
When LPL activity is returned to baseline levels and
IMTG stores are replenished, the attenuating effect of
previous exercise on PPL appears to be absent. In com-
bination, LPL activity and IMTG storage may help ex-
plain why the lipid-lowering effects of an exercise
training program appear to be so transient.
Despite the apparent brevity of several of the PPL-
lowering adaptations from exercise, there does appear to
be some benefit of prior training status with regard to
PPL. In a study performed by Tsetsonis, Hardman, and
Mastana (1997), trained and untrained (VO2 max 50.3 ±
5.9, 31.7 ± 3.6 ml/kg/min respectively) middle-aged
women completed a bout of exercise of similar duration
and intensity (90 min at 60% VO2 max), 16 h prior to in-
gestion of a high-fat meal. There was no significant dif-
ference in lipemia between groups after their non-
exercise control sessions, but trained women had a 30%
reduction in lipemia when compared to untrained
women the morning following the exercise session [88].
However, since the relative exercise intensity of each
group was the same, but the aerobic capacity of the
trained group was higher, the trained group achieved a
greater overall energy expenditure. Greater energy ex-
penditures achieved during shorter durations of exercise
performed at the same relative exercise intensity for
trained subjects as compared to untrained subjects, pro-
vide a potential explanation for the lower PPL responses
in trained subjects. The attenuated PPL response in
trained participants may also be due to upregulated tri-
glyceride clearing mechanisms and enhanced ability to
use fat for fuel during exercise (increased mitochondrial
and capillary density perhaps) over untrained subjects.
Acute exercise, timing and PPL
Exercise performed during the timeframe between 18 h
pre-meal, until around 90 min post-meal may be effective
in attenuating PPL. Gill et al. (2004) showed that exercise
in the 12–18 h range prior to ingestion of a high-fat meal
attenuated the lipemic response to a high-fat meal [89].
Additionally, Zhang et al. (2004) showed an attenuation of
PPL in participants that exercised 12 h, but not 24 h prior
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to a high-fat meal [90]. However, Johnson et al. (2015)
found that exercise 12 h prior to a HFM was ineffective
for attenuating PPL even though Johnson et al. and Zhang
et al. both had participants exercise at 60% VO2 max for
60 min [46]. Additionally, exercise performed immediately
before ingestion of a HFM has also been shown to be ef-
fective for attenuating PPL [90, 91]. Collectively, this evi-
dence reinforces the idea that pre-meal exercise benefits
for PPL are relatively acute and are highly dependent on
energy expenditure and participant characteristics. Pre-
meal exercise beyond 18–24 h prior to a HFM, likely has
little effect on PPL. In addition to pre-meal exercise, evi-
dence also supports exercise during the post-meal period
as an effective means for attenuation of PPL, the majority
of work in this area has suggested that exercise performed
as far as 90 min into the postprandial period is effective
for attenuating PPL [92, 93], however this evidence is con-
flicting [77, 78].
The mechanisms for exercise-induced attenuation of
PPL may differ slightly depending on the timing of the
relationship between the bout of exercise and the
ingested meal. Exercise performed well in advance of the
meal (12-18 h) may attenuate PPL via increased LPL ex-
pression on the surface of the vascular endothelium [94].
LPL expression in response to exercise appears to in-
crease between 4–8 h post-exercise [95], returning to
baseline levels around 20 h post-exercise [96], which
may explain the lack of PPL attenuation when exercise
is performed 24 h or more before the meal. Exercise per-
formed immediately before the meal may attenuate PPL
through a decreased hepatic secretion of VLDLs [97].
Prolonged exercise is thought to reduce fatty acid syn-
thesis, increase fatty acid oxidation and cause accumula-
tion of TRG in the liver in response to prolonged
exercise. It has also been shown that circulating VLDL
concentrations are decreased at 4.5 h post-exercise
under post-absorptive conditions [98]. Bellou et al. 2013
showed that women decreased the TRG content of their
VLDL by 30% the morning after an exercise session.
These women decreased both their hepatic TRG secre-
tion and increased their TRG clearance; the latter likely
due to increased LPL activity, although LPL was not
measured [99]. Overall it appears that for exercise per-
formed before a high-fat meal, PPL attenuation is ini-
tially due to decreased hepatic VLDL secretion, and as
more time passes between the exercise bout and meal
ingestion, LPL activity gradually becomes a more prom-
inent factor leading to greater TRG clearance from cir-
culation. However, Sondergaard et al. 2011 did not find
an increase in TRG clearance during or following exercise,
but rather, a slight nonsignificant decrease in TRG clearance
during both time periods [97]. These contrasting results
may be partially due to differences in exercise intensity and
energy expenditure between studies. Participants in the
Bellou et al. 2013 study exercised at 60% VO2 max for an
average of 123 min, while participants in the Sondergaard et
al. 2011 study exercised at 50% VO2 max for 90 min. These
constrasting findings highlight the difficulty in accurately
measuring and interpreting lipid kinetics during exercise, es-
pecially when there are differences in study design [97, 99].
PPL lowering mechanisms for post-meal exercise ap-
pear to be similar to that of pre-meal exercise. A small
but significant amount of circulating TRG may contrib-
ute to total energy expenditure during exercise; however,
the absolute rate of VLDL oxidation during exercise is
not different compared to resting conditions [97]. Add-
itionally, greater blood flow through the vasculature dur-
ing exercise leads to increased contact time between
TRG and LPL and more opportunity for TRG to be hy-
drolyzed. Lastly, in a similar manner to pre-meal exer-
cise, post-meal exercise may decrease hepatic fatty acid
synthesis and reduce VLDL accumulation in the blood-
stream [97]. (The mechanisms for exercise-induced at-
tenuation of PPL are included in Fig. 2).
Exercise energy expenditure, intensity and energy
balance and PPL
Energy expenditure
Exercise frequency, intensity, duration, and energy ex-
penditure are all important considerations for a
complete exercise program. When specifically targeting
attenuation of PPL, overall energy expenditure may be
the most influential factor to consider. In a previous re-
view by Petitt and Cureton (2003), the authors con-
cluded that the magnitude of prior exercise induced
energy expenditure appears to directly determine the
magnitude of PPL attenuation [100].
Previous research has attempted to determine a
threshold for energy expenditure needed to attenuate
PPL. Researchers have shown energy expenditures in ex-
cess of 1000 kcal can effectively attenuate PPL [13, 101].
However, studies using such large energy expenditures
are not representative of an energy expenditure that is
realistic for most individuals to achieve during regular
bouts of exercise. Energy expenditures of this magnitude
are most likely only achieved by highly trained individ-
uals with aerobic capacities exceeding that of the general
population. However, some evidence suggests that obese
individuals and those with lower aerobic capacities may
require less exercise energy expenditure to attenuate
PPL. In less aerobically fit men, relatively low energy ex-
penditures both prior to, and post-exercise have been
shown to attenuate PPL. The pre-meal exercise bout
used in one study resulted in an energy expenditure of
less than 500kcals [102]. A separate study found a post-
prandial walk of only 30 min was also effective for at-
tenuating PPL [103]. Other studies that have tested
recreational exercisers have shown that these individuals
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may require energy expenditures in the 600-900 kcal
range in order to attenuate PPL [104, 105]. Therefore, it
appears that individuals who exercise less frequently
may need to expend less energy during exercise to at-
tenuate PPL. However, individuals who exercise more
frequently and have higher aerobic capacities, may re-
quire a higher energy expenditure to attenuate PPL.
Intensity
Exercise intensity is highly related to exercise energy ex-
penditure, and previous research has explored the ques-
tion of what exercise intensity is required for a reduction
in PPL. Low intensity exercise performed the evening
before (15 h prior) a high-fat meal has been shown to be
effective for attenuating PPL [106]. However, to achieve
an adequate energy expenditure to attenuate PPL at a
low-intensity, this bout of exercise took 120 min to
complete, which is a duration that may be unattainable
for most individuals on a daily basis. Further, when low-
intensity exercise was performed for only 90 min, no at-
tenuation of PPL was shown [101]. Moderate-intensity
exercise, however, has been shown to attenuate PPL with
a duration more representative of typical exercise habits.
Zhang et al. (1998) showed that 60 min of moderate-
intensity exercise (60% VO2 max) was effective for
attenuating PPL when performed one hour or 12 h prior
to a HFM [91]. To further support the benefits of
moderate-intensity exercise, two previous studies have
indicated that as little as 30 min of brisk walking at a
moderate-intensity can be effective for attenuating PPL
[102, 107]. Both of these studies compared continuous
exercise to shorter, intermittent bouts and found both
types of exercise to be equally effective. Furthermore,
prior high-intensity exercise has also been found to be
an effective modality for reducing PPL following a HFM
[17]. This effect has been show through both cycling and
treadmill running [108, 109]. Additionally, the benefits
of high-intensity exercise have also been shown in youth
populations, where higher exercise intensities are more
likely to be achieved than in adult populations [110,
111]. A recent quantitative review by Freese et al. 2014,
compared high-intensity exercise to low-to-moderate in-
tensity aerobic exercise. One of the meta-analyses from
that review revealed that high-intensity exercise induced
a greater attenuation of PPL (d = 1.49) as compared to
aerobic exercise at lower intensities (d = 0.58) [17]. Col-
lectively, it appears that high-intensity exercise prior to a
HFM may be advantageous as compared to lower-
intensity exercise in regard to time and PPL attenuation
per amount of energy expended. However, due to the
Fig. 2 The proposed anti-inflammatory effect of acute aerobic exercise. Triglyceride rich lipoproteins (TRL), High-density lipoprotein cholesterol (HDL),
Low-density lipoprotein cholesterol (LDL), Very-low density lipoprotein cholesterol (VLDL), Interleukin-1 (IL-1), Interleukin-6 (IL-6), Interleukin-10 (IL-10),
Tumor Necrosis Factor- α (TNF- α). Acute aerobic exercise decreases circulating triglycerides through increased TRL clearance from circulation, decreased
TRL appearance from the small intestine, decreased VLDL secretion from the liver, and increased lipolysis and fat oxidation. Each of these processes
contributes to lower PPL, increased HDL, decreased TRL resident time in circulation, and decreased LDL oxidation. These processes combine to create a
less inflammatory environment within the vasculature. Muscle contractions during aerobic exercise release the anti-inflammatory cytokines IL-6 and IL-10.
These cytokines inhibit production of pro-inflammatory cytokines TNF- α and IL-1 leading to lower inflammation within the vasculature
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strenuous nature of higher-intensity exercise, it should
be recommended that individuals exercise at an intensity
level that is safe for them individually, especially in high-
risk populations.
Although post-meal exercise has been less frequently
studied compared with pre-meal exercise, similar exer-
cise intensities appear to be beneficial for both time-
frames. Moderate-intensity exercise in the postprandial
period has been shown to be effective for attenuating
PPL [93]. However, low-intensity exercise with compar-
able timing has produced mixed results; some re-
searchers have shown lower-intensity exercise to be
effective for attenuating PPL [92], others have not [112].
However, similar to pre-meal exercise, low-intensity ex-
ercise was only effective for attenuation of PPL after a
long 90 min bout of exercise [93]. At the present time,
little evidence regarding high-intensity exercise in the
postprandial period is available, possibly due to gastro-
intestinal distress that may occur if high-intensity exer-
cise is performed immediately following a HFM. Overall,
it appears that moderate-to-high intensity aerobic exer-
cise, may be the most effective for attenuating PPL.
However, considerations must be made for each individ-
ual’s health, exercise capabilities, and available time be-
fore engaging in strenuous exercise, particularly in the
immediate timeframe around a HFM.
Energy balance
Prior exercise has been consistently shown to be an ef-
fective way to attenuate PPL [81, 113], however, the rela-
tionship between overall energy balance, exercise, and
PPL is still not fully understood. In one study, when par-
ticipants replaced 110% of the calories expended during
exercise with a meal replacement drink, the triglyceride
lowering effects of a bout of exercise were no longer
present [114]. In a different study where participants
performed long, exhaustive bouts of exercise. Partici-
pants either remained in negative energy balance, or re-
placed oxidized carbohydrates with a high-glycemic-load
drink. Participants who consumed the carbohydrate re-
placement beverage following exercise did not have an
attenuated PPL response [115]. However, Chiu et al.
(2014) found reduced TRG concentrations the morning
following moderate-intensity exercise even after post-
exercise glucose replacement [116]. Contrasting results
between studies may be due to different exercise inten-
sities effecting the energy substrate used during exercise.
Also, different participant characteristics (mainly age
and obesity status) may affect participants’ ability to
metabolize energy replacement carbohydrates.
The comparative roles of diet-induced versus exercise-
induced energy deficit has also been investigated. Using
a novel study design, Maraki et al. (2010), examined en-
ergy deficit through dietary restriction alone, exercise
induced, or a combination of both. Results indicated that
all three groups had an attenuated PPL response, with
the exercise induced energy deficit group achieving the
greatest attenuation [117]. These findings are in agree-
ment with a study by Gill and Hardman (2000) that
found a non-significant reduction in postprandial triglyc-
erides by energy restriction alone, but an exercise in-
duced energy deficit to be three times as effective as
energy restriction alone [118]. Maraki and Sidossis
(2010) reviewed the effect of negative energy balance on
PPL and concluded that for aerobic exercise to be
effective for reducing PPL, an energy deficit of around
7 kcal/kgbw is required [119]; this equates to about
60 min of moderate-intensity exercise or 120 min of
low-intensity exercise. Collectively, it appears an energy
restrictive diet and an energy deficit created through ex-
ercise may both contribute to reductions in PPL, how-
ever exercise induced energy deficits may result in a
greater magnitude of reduction.
Resistance exercise and PPL
The majority of previous research on exercise and PPL
has employed low-to-moderate intensity aerobic exer-
cise, but there is also supporting evidence indicating that
prior acute resistance exercise may also attenuate PPL
[120, 121], however this evidence is not conclusive
[122]. A direct comparison of the PPL lowering effects
of resistance exercise to aerobic exercise showed that
acute resistance exercise was as effective at reducing
PPL in women [123]. In this study, women completed
separate trials of 60 min of moderate aerobic exercise
and 60 min of resistance training with similar resultant
attenuation of PPL even though the resistance exercise
bout likely provided a lower total energy expenditure
than the aerobic exercise [123]. In regard to exercise in-
tensity, it does not appear that the PPL attenuation is
any different following moderate vs. high-intensity resist-
ance exercise when total exercise volume remains con-
stant [121]. Additionally, increased exercise volume and
total energy expenditure during an acute bout of resist-
ance exercise does not result in greater attenuation of
PPL the morning after exercise, when total energy bal-
ance remains constant [124]. These findings reinforce
the major role that total energy balance plays in the rela-
tionship between all forms of exercise (aerobic and re-
sistance) and PPL.
Exercise and PPL in youth populations
Risk factors for the disease process of atherosclerosis
have been shown to begin early in life [125], therefore it
is important to examine the potential PPL reducing ef-
fects of exercise in youth populations. Tolfrey et al. re-
cently reviewed this topic and found the effects of
exercise on PPL to be similar in adult and youth
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populations [126]. For example, moderate-intensity exer-
cise appears to both lower PPL [127] and improve endo-
thelial function [128] the morning after exercise.
Notably, the positive effects of intermittent exercise and
high-intensity interval training, may be especially advan-
tageous in youth, due to the often spontaneous nature of
youth exercise and an increased ability to handle high-
intensity exercise bouts as compared to adult popula-
tions [110, 129, 130]. Youth populations should be en-
couraged to meet physical activity guidelines and engage
in high-intensity exercise when possible. Meeting such
guidelines will likely reduce the likelihood of developing
atherosclerotic lesions that may be present in some
youth populations [131].
The anti-inflammatory effect of acute exercise
Inflammatory cytokines during and immediately after
exercise can be difficult to measure and achieve consist-
ent results. However, previous literature supports an
anti-inflammatory effect for exercise, even when studied
acutely. As an example, IL-6 has been extensively stud-
ied as both a pro- and anti-inflammatory cytokine. IL-6
has be shown to increase nearly exponentially (up to 100
fold) when released from contracting skeletal muscle
during exercise [132]. IL-6 has also been shown to in-
crease in response to greater exercise intensity and dur-
ation. When released from skeletal muscle, IL-6 appears
to be anti-inflammatory and has been shown to increase
lipolysis and fat oxidation without an increase in circu-
lating TRG [133]. Increased IL-6 production during ex-
ercise has an inhibitory effect on both TNF-α and IL-1
[134] and increases production of the anti-inflammatory
cytokine IL-10 [134]. Subsequently, IL-10 has been
shown to inhibit the production of many pro-
inflammatory cytokines including: IL-1β, TNF-α, and
[135]. Together these mechanisms could explain the
anti-inflammatory effects of IL-6 secreted by skeletal
muscle during exercise. (The anti-inflammatory effect of
acute aerobic exercise is included in Fig. 2).
Chronic exercise and systemic inflammation
As more research has established atherosclerosis as an in-
flammatory disease, many studies have examined the rela-
tionships between long-term exercise habits, aerobic
fitness, and systemic inflammation. Highly active individ-
uals typically display lower levels of circulating systemic in-
flammation, compared to low-active individuals [136, 137].
In a study by Fischer et al. (2007), eighty-four healthy
adults were divided into four groups based on presence or
absence of obesity and their typical physical activity level
[138]. The authors found elevated levels of IL-6 and CRP
in inactive individuals to be independent risk factors for
systemic inflammation even after controlling for obesity,
age, gender, and smoking status. In agreement with these
findings, epidemiological evidence suggests an inverse
relationship between physical activity and several pro-
inflammatory biomarkers, including IL-6 and TNF-α [139].
However, exercise intervention trials have been less conclu-
sive with regard to the beneficial effects of frequent
exercise on inflammation markers. Results from one meta-
analysis revealed a non-significant three percent reduction
of CRP among exercise intervention trials lasting a mini-
mum of four weeks [140]. Beavers et al. (2010), reviewed
the effects of exercise interventions on systematic inflam-
mation and found 6 out of 12 studies reduced inflamma-
tion, 5 of which included CRP. Exercise intervention
studies that include participants with high levels of system-
atic inflammation due to obesity or a chronic disease, are
more likely to show reductions in systemic inflammation
during the course of an exercise intervention than studies
with healthy participants who already have low levels of in-
flammation [141]. Thus, it appears that the short-term
effectiveness of exercise interventions for reducing inflam-
mation may largely depend on participant characteristics at
baseline, but it has been consistently shown that patterns
of frequent exercise in the long-term appear to result in
lower levels of systemic inflammation [15, 140]. Dixon et
al. (2009) performed a study to examine whether or not
higher levels of long-term physical activity resulted in a
lower postprandial inflammatory response. Participants
were split into two groups: active participants were those
who participated in greater than 90 min of vigorous activity
per week and 30 min of moderate activity 5 days/week; in-
active subjects engaged in no vigorous activity and 30 min
of moderate activity less than 5 days/week. Results indi-
cated that active subjects had lower postprandial glucose,
insulin, and TRG concentrations, but there were no differ-
ences in postprandial inflammatory markers between
groups [136]. Based on these data, it is evident that fre-
quent exercise is moderately effective for reducing long-
term systemic inflammation, but this relationship does not
appear to effect the acute inflammatory response following
a HFM. It is possible that the role of exercise as an anti-
inflammatory agent may be more related to long-term
adaptations to frequent bouts of exercise that result in
physiological changes in the vasculature and skeletal
muscle at the cellular level. Increased capacity to
metabolize lipids for fuel and an increased anti-oxidant
capacity in more aerobically fit individuals may result in an
improved ability to handle large metabolic loads and main-
tain lower levels of chronic, systematic inflammation when
compared to less frequent exercisers wither lower levels of
aerobic fitness.
Resistance exercise and inflammation
The majority of studies examining exercise and the in-
flammatory response have focused on endurance aerobic
exercise, but there is evidence to suggest an inflammatory
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effect from acute resistance exercise as well. Similarly to
endurance exercise, IL-6 appears to increase between 3
and 6 h after a resistance exercise session, albeit to a lesser
magnitude than after endurance exercise [142]. Addition-
ally, TNF- α does not appear to increase following acute
resistance training [143] and may even decrease [144]. Evi-
dence of long-term effects of resistance exercise on resting
inflammatory markers appears to be weaker than evidence
for acute effects. For example, in one study that included
a 12-week resistance training program, resting levels of in-
flammatory cytokines were not lowered, with the excep-
tion of CRP [145]. However, it does appear that resistance
trained individuals have upregulated mRNA expression of
anti-inflammatory cytokines such as IL-6 and IL-10 as
compared to non-resistance trained individuals [146].
Acute exercise and postprandial inflammation
The effects of an acute bout of exercise on postprandial
inflammation are relatively unknown. Experimental
studies aimed at reducing postprandial inflammation
through exercise have focused primarily on moderate-
to-high intensity pre-meal exercise [104, 105]. While
these studies have found prior exercise to be effective
for attenuating PPL, they have not found acute exercise
to be effective for decreasing postprandial inflammation.
Other mechanisms, in addition to PPL may be respon-
sible for the pro-inflammatory environment seen follow-
ing a HFM. Experimental studies have examined the
relationship between prior exercise and postprandial
markers of oxidative stress and endothelial function
[109, 147]. These studies have shown that bouts of mod-
erate and high-intensity exercise may be able to diminish
or prevent increases in oxidative stress and endothelial
dysfunction caused by a HFM. This may be due to an in-
creased anti-oxidant capacity during exercise. Increased
ROS during exercise may signal to the muscle to in-
crease antioxidant capacity. Muscle cell adaptations to
reduce ROS during exercise may also result in an overall
protection against ROS at rest [148]. Overall, it appears
that moderate to high-intensity aerobic exercise prior to
a HFM is effective for attenuating PPL, oxidative stress,
and endothelial function. However, studies that have
used acute bouts of exercise prior to a HFM have not
provided any evidence to indicate beneficial effects on
postprandial pro-inflammatory cytokine concentrations.
Future directions
As opposed to focusing exclusively on exercise prior to a
HFM, future studies should also directly examine post-
prandial exercise as a potential modality to reduce both
postprandial inflammation and lipemia. Additional focus
should be placed on more true-to-life investigations into
the interaction between diet and exercise as they related
to postprandial lipemia and inflammation. Meal sizes
proportional to the body size of participants; exercise of
realistic duration, intensity, and total volume; and meals
and exercise occurring in a time window when individ-
uals typically eat before or after exercise should be inves-
tigated further. Evidence from such investigations could
provide more pragmatic information for health profes-
sionals to provide to clients who are trying to improve
their blood lipid profile or reduce overall CVD risk.
Conclusion
Acute exercise from 18 h prior to a HFM until 90 min after
a HFM has been shown to be effective in attenuating PPL.
Exercise at a moderate-intensity for a 60 min duration has
been shown in several different studies to attenuate PPL,
this is a recommendation that may be achievable as com-
pared to bouts of low-intensity exercise of 120 min dur-
ation. Although 60 min of moderate exercise has been
shown to be effective for reducing PPL, studies thus far
have not demonstrated that an acute bout of exercise is ef-
fective for attenuating postprandial inflammation. Many
studies, however, have indicated that long-term frequent
exercisers have lower basal systemic inflammation as com-
pared to less frequent exercisers. Yet, without the presence
of a recent bout of exercise, high levels of chronic exercise
do not appear to reduce PPL. It may be practical for health
practitioners to prescribe frequent exercise at a moderate-
intensity to consistently attenuate PPL and lower systemic
inflammation over time. Combined with more moderate
sized meal portions, this recommendation could protect in-
dividuals from metabolic stress and may result in lower
PPL and postprandial inflammation long term.
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